Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
Australia
GenesisCare North Shore, St Leonards, New South Wales The Royal Melbourne Hospital, Melbourne, Victoria Peninsula & South Eastern Haematology and Oncology Group, Melbourne, Victoria